Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Journal of the American Academy of Dermatology|May 21, 2020
Deep learning for dermatologists: Part I. Fundamental conceptsDennis H Murphree, Pranav Puri, Huma Shamim, et al.Journal of the American Academy of Dermatology|May 20, 2020
Deep learning for dermatologists: Part II. Current applicationsPranav Puri, Nneka Comfere, Lisa A Drage, et al.JAMA Dermatology|February 6, 2020
A Comparison of Psoriasis Severity in Pediatric Patients Treated With Methotrexate vs Biologic AgentsInge M G J Bronckers, Amy S Paller, Dennis P West, et al.Journal of the American Academy of Dermatology|February 22, 2016
Guidelines of care for the management of acne vulgarisAndrea L Zaenglein, Arun L Pathy, Bethanee J Schlosser, et al.JAMA Dermatology|June 16, 2021
Association of Demographic Factors and Infantile Hemangioma Characteristics With Risk of PHACE SyndromeColleen H Cotton, Jusleen Ahluwalia, Daniel M Balkin, et al.JAMA Dermatology|December 12, 2019
Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE SyndromeGerilyn M Olsen, Leanna M Hansen, Nicole S Stefanko, et al.Pediatric Dermatology|April 17, 2020
Management of infantile hemangiomas during the COVID pandemicIlona J Frieden, Katherine B Püttgen, Beth A Drolet, et al.The Journal of Investigative Dermatology|November 28, 2017
Analyzing the Genetic Spectrum of Vascular Anomalies with Overgrowth via Cancer GenomicsDawn H Siegel, Catherine E Cottrell, Jenna L Streicher, et al.Pediatric Dermatology|April 23, 2020
Systemic immunosuppressive therapy for inflammatory skin diseases in children: Expert consensus-based guidance for clinical decision-making during the COVID-19 pandemicSean D Reynolds, Anubhav N Mathur, Yvonne E Chiu, et al.Pediatric Dermatology|June 23, 2022
Successful use of telemedicine for evaluation of infantile hemangiomas during the early COVID-19 pandemic: A cross-sectional studyNicole W Kittler, Ilona J Frieden, Katrina Abuabara, et al.Pageof 12